Genesis Investment Funds Limited
Genesis Biotechnology Fund
(In Liquidation)



Performance
Last valuation date:

NAV per Share:

Performance:
1.11.2007

USD 215.73

Year to date:
61.58%

Since inception:
115.73%
Next NAV Date: 1.8.2013
Performance Graph
Performance Graph

Directory
Valoren Number:
2 244 439

ISIN:
VCP4828X1027

Bloomberg Ticker:
GBIOTEC EK

WKN:
A0LCC4

Fund Manager:
Genesis Capital Management Limited

Fund Administrator:
Regent Fund Management Limited

Custodian:
PHZ Bank

Registrar & Transfer Agent:
Regent Fund Management Limited

Auditor:
BDO AG

Registered Jurisdiction:
St. Vincent & the Grenadines

Fund Website:
www.genesisinvestmentfunds.com